Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Community fixed-dose combination antihypertensive therapy study
ChiCTR-TRC-08000320Phase 4Completed
- Sponsor
- Fuwai Hospital
- Start
- Sep 2008
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of reserpine and reserpine + triamterene in hypertension (HTN) (2 arms), sponsored by Fuwai Hospital. Primary endpoints: Cost-effectiveness, Cardiovascular disease events and 1 more. Started Sep 2008; status: completed.
02
Drugs
reserpinereserpine + triamterene
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on ChiCTR-TRC-08000320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000320.